Immunic Inc (IMUX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IMUX Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Immunic Inc finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent186.63
Cash & Short-term Investments186.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.13
Total Current Assets188.76
Equipment/Property/Plant Net0.57
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset0.42
Total Assets189.74
Liabilities
Accounts Payable, Current AC11.01
Accrued Liabilities, Current AC22.43
Other Liabilities, Current4.92
Total Current Liabilities38.36
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Noncurrent0.15
Total Liabilities38.51
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock789.32
Retained Earnings / Accumulated Deficit-641.16
Other Equity3.06
Common Stockholder's Equity151.23
Total Stockholder's Equity151.23
Liabilities & Stockholder's Equity189.74
4 historic quarters locked

Sign in to unlock the full Immunic Inc balance sheet history.

About Immunic Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 11, 2026
  • Source: vtl-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001280776-26-000018

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.